Dawnrays Pharmaceutical (Holdings) Past Performance
How has Dawnrays Pharmaceutical (Holdings) performed over the past 5 years?
Past Performance Score
5/6Past Performance Score 5/6
Quality Earnings
Growing Profit Margin
Earnings Trend
Accelerating Growth
Earnings vs Industry
High ROE
2.9%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 2348 has high quality earnings.
Growing Profit Margin: 2348's current net profit margins (30.8%) are higher than last year (26.7%).
Past Earnings Growth Analysis
Earnings Trend: 2348's earnings have grown by 2.9% per year over the past 5 years.
Accelerating Growth: 2348's earnings growth over the past year (19%) exceeds its 5-year average (2.9% per year).
Earnings vs Industry: 2348 earnings growth over the past year (19%) exceeded the Pharmaceuticals industry 5.2%.
Return on Equity
High ROE: 2348's Return on Equity (14.5%) is considered low.